DE602008004769D1 - Hetarylaniline als modulatoren für amyloid beta - Google Patents
Hetarylaniline als modulatoren für amyloid betaInfo
- Publication number
- DE602008004769D1 DE602008004769D1 DE602008004769T DE602008004769T DE602008004769D1 DE 602008004769 D1 DE602008004769 D1 DE 602008004769D1 DE 602008004769 T DE602008004769 T DE 602008004769T DE 602008004769 T DE602008004769 T DE 602008004769T DE 602008004769 D1 DE602008004769 D1 DE 602008004769D1
- Authority
- DE
- Germany
- Prior art keywords
- hetarylaniline
- modulatoren
- für
- als
- amyloid beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000013455 Amyloid beta-Peptides Human genes 0.000 title 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07108004 | 2007-05-11 | ||
| PCT/EP2008/055290 WO2008138753A1 (en) | 2007-05-11 | 2008-04-30 | Hetarylanilines as modulators for amyloid beta |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602008004769D1 true DE602008004769D1 (en) | 2011-03-10 |
Family
ID=39758855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602008004769T Active DE602008004769D1 (en) | 2007-05-11 | 2008-04-30 | Hetarylaniline als modulatoren für amyloid beta |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7910740B2 (de) |
| EP (1) | EP2155740B1 (de) |
| JP (1) | JP5264890B2 (de) |
| KR (1) | KR101138045B1 (de) |
| CN (1) | CN101675045B (de) |
| AR (1) | AR066509A1 (de) |
| AT (1) | ATE496915T1 (de) |
| AU (1) | AU2008250436B2 (de) |
| BR (1) | BRPI0811993A2 (de) |
| CA (1) | CA2686754C (de) |
| CL (1) | CL2008001347A1 (de) |
| DE (1) | DE602008004769D1 (de) |
| ES (1) | ES2358863T3 (de) |
| IL (1) | IL201566A (de) |
| MX (1) | MX2009012163A (de) |
| PE (1) | PE20090248A1 (de) |
| RU (1) | RU2009140182A (de) |
| TW (1) | TW200904420A (de) |
| WO (1) | WO2008138753A1 (de) |
| ZA (1) | ZA200907585B (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2566094A1 (en) * | 2004-05-26 | 2005-12-08 | Eisai R & D Management Co., Ltd. | Cinnamide compound |
| ES2338904T3 (es) * | 2004-10-26 | 2010-05-13 | EISAI R&D MANAGEMENT CO., LTD. | Forma amorfa de compuestos de cinamida. |
| EP1953151A4 (de) * | 2005-11-18 | 2010-06-02 | Eisai R&D Man Co Ltd | Salze aus einer cynnamidverbindung oder solvate daraus |
| US20090270623A1 (en) * | 2005-11-18 | 2009-10-29 | Naoyuki Shimomura | Process for production of cinnamide derivative |
| CA2629745A1 (en) * | 2005-11-24 | 2007-05-31 | Eisai R & D Management Co., Ltd. | Morpholine type cinnamide compound |
| TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| AR062095A1 (es) * | 2006-07-28 | 2008-10-15 | Eisai R&D Man Co Ltd | Profarmaco de compuesto cinamida |
| US20080153863A1 (en) | 2006-12-22 | 2008-06-26 | Caterina Bissantz | Spiropiperidine derivatives |
| US20080207900A1 (en) * | 2007-02-28 | 2008-08-28 | Teiji Kimura | Two cyclic oxomorphorin derivatives |
| CA2687262A1 (en) * | 2007-05-16 | 2008-11-20 | Naoyuki Shimomura | One-pot production process for cinnamide derivative |
| CN101815713B (zh) | 2007-08-31 | 2013-09-11 | 卫材R&D管理有限公司 | 多环化合物 |
| US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| CN101903372B (zh) * | 2007-12-21 | 2014-06-18 | 弗·哈夫曼-拉罗切有限公司 | 作为食欲肽受体拮抗剂的杂芳基衍生物 |
| RU2010132728A (ru) * | 2008-01-11 | 2012-02-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Модуляторы бета-амилоида |
| CA2712095A1 (en) * | 2008-01-28 | 2009-08-06 | Eisai R&D Management Co., Ltd. | Crystalline cinnamide compounds or salts thereof |
| JP5328816B2 (ja) * | 2008-02-22 | 2013-10-30 | エフ．ホフマン−ラ ロシュ アーゲー | アミロイドβの調節薬 |
| JP5502089B2 (ja) * | 2008-10-09 | 2014-05-28 | エフ．ホフマン−ラ ロシュ アーゲー | アミロイドβのモジュレーター |
| WO2010053438A1 (en) * | 2008-11-06 | 2010-05-14 | Astrazeneca Ab | Modulators of amyloid beta. |
| MX2011004954A (es) | 2008-11-10 | 2011-05-30 | Hoffmann La Roche | Moduladores heterociclicos de gamma-secretasa. |
| PA8854101A1 (es) * | 2008-12-18 | 2010-07-27 | Ortho Mcneil Janssen Pharm | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa |
| TW201030002A (en) | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
| MX2011008335A (es) | 2009-02-06 | 2011-09-06 | Ortho Mcneil Janssen Pharm | Novedosos compuestos heterociclicos biciclicos sustituidos como moduladores de la gamma secretasa. |
| TWI461425B (zh) | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
| NZ596843A (en) * | 2009-05-07 | 2012-12-21 | Janssen Pharmaceuticals Inc | Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators |
| UY32622A (es) * | 2009-05-12 | 2010-12-31 | Astrazeneca Ab | Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta) |
| JP2012532912A (ja) | 2009-07-15 | 2012-12-20 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | ガンマセクレターゼモジュレーターとしての置換されたトリアゾールおよびイミダゾール誘導体 |
| CA2784769A1 (en) | 2010-01-15 | 2011-07-21 | Janssen Pharmaceuticals, Inc. | Novel substituted triazole derivatives as gamma secretase modulators |
| US20110190269A1 (en) * | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
| US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
| JP2014508794A (ja) | 2011-03-24 | 2014-04-10 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | γ−セクレターゼ調節剤としての新規な置換トリアゾリルピペラジンおよびトリアゾリルピペラジン誘導体 |
| JP5767393B2 (ja) | 2011-03-31 | 2015-08-19 | ファイザー・インク | 新規二環式ピリジノン |
| US9115143B2 (en) | 2011-07-15 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | Substituted indole derivatives as gamma secretase modulators |
| JP6106745B2 (ja) | 2012-05-16 | 2017-04-05 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | （特に）アルツハイマー病の治療に有用な置換３，４−ジヒドロ−２Ｈ−ピリド［１，２−ａ］ピラジン−１，６−ジオン誘導体 |
| UA110688C2 (uk) | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
| ES2608356T3 (es) | 2012-12-20 | 2017-04-10 | Janssen Pharmaceutica Nv | Novedosos derivados tricíclicos de 3,4-dihidro-2H-pirido[1,2-a]pirazin-1,6-diona como moduladores de la secretasa gamma |
| CN104936958B (zh) | 2013-01-17 | 2019-07-26 | 詹森药业有限公司 | 作为γ分泌酶调节剂的新颖的经取代的吡啶并-哌嗪酮衍生物 |
| CN103664819A (zh) * | 2013-12-16 | 2014-03-26 | 山东汇海医药化工有限公司 | 一种2-氨基-4-甲基噻唑-5-甲酸乙酯的制备方法 |
| US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
| PE20171318A1 (es) | 2015-02-03 | 2017-09-07 | Pfizer | Ciclopropabenzofuranil-piridopirazindionas novedosas |
| US20190071450A1 (en) * | 2016-03-11 | 2019-03-07 | Ac Immune Sa | Bicyclic compounds for diagnosis and therapy |
| CN109476670B (zh) * | 2016-10-04 | 2022-06-28 | 豪夫迈·罗氏有限公司 | 二环杂芳基衍生物 |
| CN110194764B (zh) * | 2018-02-26 | 2022-08-16 | 云南大学 | 酰胺类化合物、其制备方法及用途 |
| PT3846903T (pt) | 2018-09-03 | 2023-12-14 | Hoffmann La Roche | Derivados heteroarílicos bicíclicos |
| SG11202103340PA (en) | 2018-12-13 | 2021-04-29 | Hoffmann La Roche | 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease |
| CN114222732B (zh) * | 2019-10-28 | 2023-04-04 | 南京明德新药研发有限公司 | 一种尿酸促排剂及其合成方法和其在医药上的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200001081T2 (tr) * | 1997-10-27 | 2000-10-23 | Agouron Pharmaceuticals, Inc. | CDKS inhibitörleri olarak ikame edilmiş 4-amino tiyazol-2-il bileşikleri |
| JP2002518380A (ja) * | 1998-06-18 | 2002-06-25 | ブリストル−マイヤーズ スクイブ カンパニー | サイクリン依存キナーゼの炭素置換アミノチアゾール抑制剤 |
| US20030176454A1 (en) * | 2000-05-15 | 2003-09-18 | Akira Yamada | N-coating heterocyclic compounds |
| MXPA05012281A (es) * | 2003-05-14 | 2006-05-19 | Torreypines Therapeutics Inc | Compuestos y uso de los mismos en la modulacion beta amiloide. |
| CA2566094A1 (en) | 2004-05-26 | 2005-12-08 | Eisai R & D Management Co., Ltd. | Cinnamide compound |
| BRPI0516915A (pt) | 2004-12-01 | 2008-03-11 | Devgen Nv | derivados de tiazol substituìdos por 5-carboxamido que interagem com canais de ìons, particularmante com canais de ìons da famìlia kv |
| US20060241038A1 (en) | 2005-04-20 | 2006-10-26 | Eisai Co., Ltd. | Therapeutic agent for Abeta related disorders |
| US20090270623A1 (en) | 2005-11-18 | 2009-10-29 | Naoyuki Shimomura | Process for production of cinnamide derivative |
| EP1953151A4 (de) | 2005-11-18 | 2010-06-02 | Eisai R&D Man Co Ltd | Salze aus einer cynnamidverbindung oder solvate daraus |
| US20070117839A1 (en) | 2005-11-24 | 2007-05-24 | Eisai R&D Management Co., Ltd. | Two cyclic cinnamide compound |
| CA2629745A1 (en) | 2005-11-24 | 2007-05-31 | Eisai R & D Management Co., Ltd. | Morpholine type cinnamide compound |
| MX2008011221A (es) | 2006-03-09 | 2008-09-11 | Eisai R&D Man Co Ltd | Compuestos de cinamida policiclicos. |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
-
2008
- 2008-04-30 AU AU2008250436A patent/AU2008250436B2/en not_active Ceased
- 2008-04-30 MX MX2009012163A patent/MX2009012163A/es active IP Right Grant
- 2008-04-30 EP EP08749887A patent/EP2155740B1/de not_active Not-in-force
- 2008-04-30 JP JP2010507876A patent/JP5264890B2/ja not_active Expired - Fee Related
- 2008-04-30 RU RU2009140182/04A patent/RU2009140182A/ru unknown
- 2008-04-30 KR KR1020097025780A patent/KR101138045B1/ko not_active Expired - Fee Related
- 2008-04-30 AT AT08749887T patent/ATE496915T1/de active
- 2008-04-30 CN CN2008800140851A patent/CN101675045B/zh not_active Expired - Fee Related
- 2008-04-30 BR BRPI0811993-7A2A patent/BRPI0811993A2/pt not_active Application Discontinuation
- 2008-04-30 DE DE602008004769T patent/DE602008004769D1/de active Active
- 2008-04-30 ES ES08749887T patent/ES2358863T3/es active Active
- 2008-04-30 WO PCT/EP2008/055290 patent/WO2008138753A1/en active Application Filing
- 2008-04-30 CA CA2686754A patent/CA2686754C/en not_active Expired - Fee Related
- 2008-05-05 US US12/114,852 patent/US7910740B2/en not_active Expired - Fee Related
- 2008-05-08 TW TW097117052A patent/TW200904420A/zh unknown
- 2008-05-08 CL CL2008001347A patent/CL2008001347A1/es unknown
- 2008-05-09 AR ARP080101972A patent/AR066509A1/es unknown
- 2008-05-09 PE PE2008000822A patent/PE20090248A1/es not_active Application Discontinuation
-
2009
- 2009-10-15 IL IL201566A patent/IL201566A/en active IP Right Grant
- 2009-10-28 ZA ZA200907585A patent/ZA200907585B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101675045B (zh) | 2012-11-28 |
| IL201566A (en) | 2013-08-29 |
| JP2010526847A (ja) | 2010-08-05 |
| MX2009012163A (es) | 2009-12-01 |
| AU2008250436A1 (en) | 2008-11-20 |
| KR101138045B1 (ko) | 2012-04-24 |
| ATE496915T1 (de) | 2011-02-15 |
| CA2686754C (en) | 2014-10-28 |
| ZA200907585B (en) | 2010-07-28 |
| AU2008250436B2 (en) | 2013-03-28 |
| JP5264890B2 (ja) | 2013-08-14 |
| US7910740B2 (en) | 2011-03-22 |
| EP2155740A1 (de) | 2010-02-24 |
| AR066509A1 (es) | 2009-08-26 |
| PE20090248A1 (es) | 2009-03-27 |
| CA2686754A1 (en) | 2008-11-20 |
| KR20100008791A (ko) | 2010-01-26 |
| BRPI0811993A2 (pt) | 2014-11-18 |
| CL2008001347A1 (es) | 2009-05-29 |
| RU2009140182A (ru) | 2011-06-20 |
| EP2155740B1 (de) | 2011-01-26 |
| WO2008138753A1 (en) | 2008-11-20 |
| CN101675045A (zh) | 2010-03-17 |
| TW200904420A (en) | 2009-02-01 |
| IL201566A0 (en) | 2010-05-31 |
| ES2358863T3 (es) | 2011-05-16 |
| US20080280948A1 (en) | 2008-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602008004769D1 (en) | Hetarylaniline als modulatoren für amyloid beta | |
| LT2842967T (lt) | Beta amiloido pegilintas fab | |
| ZA201005399B (en) | Modulators for amyloid beta | |
| IL205023A0 (en) | Modulators for amyloid beta | |
| GB2453319B (en) | Rimless toilet | |
| ZA201004620B (en) | Integrated bio-digestion facility | |
| IL202563A0 (en) | Monoclonal anti beta amyloid antibody | |
| IL196478A0 (en) | Humanized antibody against amyloid beta | |
| EP2480739A4 (de) | Befestigungsanordnung für einen türgriff | |
| EP2367826A4 (de) | Amyloid-beta-modulatoren | |
| EP2238551A4 (de) | Programm für den entwurf von massgeschneiderten z-linsen | |
| PL2509940T3 (pl) | Środki wiążące amyloidy | |
| DE112008001463A5 (de) | Bewehrungsvorrichtung für Fertigbau-Teile | |
| IL210078A0 (en) | Modulators for amyloid beta | |
| IL254065A0 (en) | Human antibody against amyloid in the cell | |
| EP2348042A4 (de) | Modifiziertes amyloid-beta-peptid | |
| GB2463219B (en) | Fixing | |
| GB0722068D0 (en) | Predictive test | |
| GB0702689D0 (en) | Touchpad | |
| GB201020403D0 (en) | Beleuchtungseinrichtung für ein kraftfahrzeug | |
| PL386231A1 (pl) | Element mocujący | |
| PL1944429T3 (pl) | Osłona rewizyjna | |
| TWI319053B (en) | Fixing mechanism | |
| GB2452302B (en) | Fixing | |
| TWI339731B (en) | Probe assembly |